Abbott has agreed to conduct postmarket studies for the ID Now device that each will include at least 150 covid-19 positive patients in a variety of clinical settings.
Read MoreAACC’s letter to Deborah Birx, MD, White House coronavirus response coordinator, regarding the need for testing supplies and personal protective equipment.
Read MoreTo diagnose covid-19, the kit is authorized to detect SARS-CoV-2 RNA from bronchoalveolar lavage, nasopharyngeal swabs, oropharyngeal swabs, and sputum.
Read More
NeuMoDx is seeking to expand the workflow of its covid-19 test to include testing of saliva specimens collected in the NeuMoDx saliva collection device.
Read MoreUsing the company’s namesake method, the covid-19 kit works by programming a CRISPR molecule to detect the genetic signature of the SARS-CoV-2 virus.
Read More